Thermo King by Trane Technologies, has expanded its portfolio of temporary storage solutions that can meet the unique requirements of global pharmaceutical companies developing COVID-19 vaccines. Thermo King is the global leader in intelligent end-to-end temperature-controlled cold chain solutions.
Pharmaceutical companies in final-stage clinical trials anticipate they will require strict temperature controls to safeguard their products – down to temperatures as low as (-) 70 degrees Celsius. Thermo King’s solutions can enable these companies and their distributors to ensure the efficacy of their products through the entire cold chain – from air transport to marine, rail, trailer, last-mile delivery and at storage points along the way.
According to the World Health Organization, nearly 20 percent of temperature-sensitive health care products are damaged during transport, and 25 percent of vaccines reach their destination in a degraded state due to breaks in the cold chain.
“Considering the urgent, global need for a COVID-19 vaccine, the world can’t afford breaks in the cold chain,” said Dave Regnery, president and chief operating officer of Trane Technologies. “Our new Cold Storage Solutions can maintain temperatures of (-) 70 degrees Celsius for an extended period of time, can be leveraged to help reduce degradation of a vaccination, and most importantly, could prevent vaccine ‘deserts’ or lack of accessibility.”
Cookie Consent
We use cookies to personalize your experience. By continuing to visit this website you agree to our Terms & Conditions, Privacy Policy and Cookie Policy.
![](https://www.thermalcontrolmagazine.com/wp-content/uploads/2024/08/thermal-control-logo.png)